ENDOSCOPIC AND HISTOLOGIC OUTCOME IN TOFACITINIB TREATED REFRACTORY MODERATE-TO-SEVERE ULCERATIVE COLITIS: A PROSPECTIVE REAL-LIFE COHORT

被引：0
|
作者：
Verstockt, Bram
Outtier, An
Lefrere, Jolien
Sabino, Joao
Vermeire, Severine
De Hertogh, Gert
Ferrante, Marc
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1858
引用
收藏
页码：S952 / S952
页数：1
相关论文
共 50 条
  • [31] Disease burden of patients with moderate to severe ulcerative colitis: A French multicenter real-life study (THEFAR)
    Fumery, Mathurin
    Altwegg, Romain
    Aygalenq, Philippe
    Filippi, Jerome
    Ghestem, Vincent
    Jamonneau, Isabelle
    Kirion, Justin
    Bouee, Stephane
    Robert, Camille
    DIGESTIVE AND LIVER DISEASE, 2025, 57 (01) : 251 - 259
  • [32] Evaluating tofacitinib citrate in the treatment of moderate-to-severe active ulcerative colitis: design, development and positioning of therapy
    Tran, Vivy
    Shammas, Rania M.
    Sauk, Jenny S.
    Padua, David
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2019, 12 : 179 - 190
  • [33] Comparative efficacy of vedolizumab and infliximab in patients with moderate-to-severe ulcerative colitis: a multicenter real world cohort study
    Sun, Y.
    Yang, H.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1555 - i1555
  • [34] Moderate-to-severe Endoscopic Inflammation is Frequent After Clinical Remission in Pediatric Ulcerative Colitis
    Sarbagili-Shabat, Chen
    Weiner, Dror
    Wardi, Joram
    Abramas, Lee
    Yaakov, Michal
    Levine, Arie
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2021, 72 (04): : 569 - 573
  • [35] TWO YEARS OF REAL-LIFE EXPERIENCE WITH USTEKINUMAB IN A SPANISH COHORT OF REFRACTORY ULCERATIVE COLITIS PATIENTS.
    Iborra, Marisa
    Ferreiro, Rocio
    Martin-Arranz, Md
    Mesonero, Francisco
    Minguez, Alejandro
    Porto-Silva, Sol
    Garcia-Ramirez, Laura
    de la Filia, Irene Garcia
    Aguas, Mariam
    Nieto-Garcia, Laura
    Ferrer, Cristina Suarez
    Bastida, Guillermo
    Barreiro-De-Acosta, Manuel
    Nos, Pilar
    GASTROENTEROLOGY, 2023, 164 (06) : S1130 - S1130
  • [36] Quality of Life in Newly Diagnosed Moderate-to-Severe Ulcerative Colitis: Changes in the MOSAIK Cohort Over 1 Year
    Jo, Ik Hyun
    Lee, Kang-Moon
    Kim, Dae Bum
    Kim, Ji Won
    Lee, Jun
    Jeen, Yoon Tae
    Kim, Tae-Oh
    Kim, Joo Sung
    Park, Jae Jun
    Hong, Sung Noh
    Park, Dong Il
    Kim, Hyun-Soo
    Lee, Yoo Jin
    Kim, Youngdoe
    GUT AND LIVER, 2022, 16 (03) : 384 - 395
  • [37] Soluble human Suppression of Tumorigenicity 2 is associated with endoscopic activity in patients with moderate-to-severe ulcerative colitis treated with golimumab
    Magro, Fernando
    Lopes, Susana
    Silva, Marco
    Coelho, Rosa
    Portela, Francisco
    Branquinho, Diogo
    Correia, Luis
    Fernandes, Samuel
    Cravo, Marilia
    Caldeira, Paulo
    de Sousa, Helena Tavares
    Patita, Marta
    Lago, Paula
    Ramos, Jaime
    Afonso, Joana
    Redondo, Isabel
    Machado, Patricia
    Philip, George
    Lopes, Joanne
    Carneiro, Fatima
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2019, 12
  • [38] TOFACITINIB INDUCES CLINICAL AND ENDOSCOPIC REMISSION IN BIOLOGIC REFRACTORY ULCERATIVE COLITIS PATIENTS: A REAL-WORLD BELGIUM COHORT STUDY
    Cremer, Anneline
    Lobaton, Triana
    Vieujean, Sophie
    Bossuyt, Peter
    Rahier, Jean-Francois
    Baert, Filip J.
    Dewit, Olivier
    Macken, Elisabeth
    Somers, Michael
    Vijverman, Anne
    Van Hootegem, Philippe
    Mana, Fazia
    Willandt, Barbara
    Caenepeel, Philip
    Humblet, Evelien
    D'Heygere, Francois
    Verreth, Annelies
    El Nawar, Abdo
    Coenegrachts, Jean-Louis
    Dewit, Sophie
    De Coninck, Steven
    Schoofs, Nele
    Delen, Stefan
    Dutre, Joris
    Thienpont, Clara
    Vanden Branden, Stijn
    Staessen, Dirk
    Franchimont, Denis
    GASTROENTEROLOGY, 2020, 158 (06) : S1208 - S1208
  • [39] Real-world Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multicentre UK Experience
    Honap, Sailish
    Chee, Desmond
    Chapman, Thomas P.
    Patel, Mehul
    Kent, Alexandra J.
    Ray, Shuvra
    Sharma, Esha
    Kennedy, James
    Cripps, Sarah
    Walsh, Alissa
    Goodhand, James R.
    Ahmad, Tariq
    Satsangi, Jack
    Irving, Peter M.
    Kennedy, Nicholas A.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (10): : 1385 - 1393
  • [40] Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting
    Gambardella, Alessio
    Licata, Gaetano
    De Rosa, Alina
    Calabrese, Giulia
    Alfano, Roberto
    Argenziano, Giuseppe
    JEADV CLINICAL PRACTICE, 2023, 2 (01): : 52 - 58
12345